Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Diseases of the Thyroid

  Free Subscription


Articles published in Anticancer Res

Retrieve available abstracts of 32 articles:
HTML format
Text format



Single Articles


    August 2019
  1. HUANG TS, Lee JJ, Li YS, Cheng SP, et al
    Ethacridine Induces Apoptosis and Differentiation in Thyroid Cancer Cells In Vitro.
    Anticancer Res. 2019;39:4095-4100.
    PubMed     Text format     Abstract available


  2. DOI K, Tsunoda T, Koyanagi M, Tanaka Y, et al
    Zfat Is Indispensable for the Development of Erythroid Cells in the Fetal Liver.
    Anticancer Res. 2019;39:4495-4502.
    PubMed     Text format     Abstract available


    July 2019
  3. STAUB Y, Nishiyama A, Suga Y, Fujita M, et al
    Clinical Characteristics Associated With Lenvatinib-induced Fistula and Tumor-related Bleeding in Patients With Thyroid Cancer.
    Anticancer Res. 2019;39:3871-3878.
    PubMed     Text format     Abstract available


    June 2019
  4. KARAGIANNIS AK, Philippou A, Tseleni-Balafouta S, Zevolis E, et al
    IGF-IEc Expression Is Associated With Advanced Differentiated Thyroid Cancer.
    Anticancer Res. 2019;39:2811-2819.
    PubMed     Text format     Abstract available


  5. MIRONSKA A, Lukaszewicz-Zajac M, Mroczko B
    Clinical Significance of Selected Chemokines in Thyroid Cancer.
    Anticancer Res. 2019;39:2715-2720.
    PubMed     Text format     Abstract available


    May 2019
  6. SAEJIA P, Lirdprapamongkol K, Svasti J, Paricharttanakul NM, et al
    Perfluorooctanoic Acid Enhances Invasion of Follicular Thyroid Carcinoma Cells Through NF-kappaB and Matrix Metalloproteinase-2 Activation.
    Anticancer Res. 2019;39:2429-2435.
    PubMed     Text format     Abstract available


  7. GADDUCCI A, Giuliani D, Cosio S, Lissoni A, et al
    Clinical Outcome of Patients With Malignant Tumors Associated With Mature Cystic Teratomas of the Ovary: A Retrospective Multicenter Italian Study.
    Anticancer Res. 2019;39:2513-2517.
    PubMed     Text format     Abstract available


    April 2019
  8. OKI T, Sugimoto T, Ogawa M, Dabanaka K, et al
    Evaluation of Follow-up Examinations Using Ultrasonography for Patients With Thyroid Nodules Initially Diagnosed as Benign.
    Anticancer Res. 2019;39:2061-2067.
    PubMed     Text format     Abstract available


    March 2019
  9. SPARTALIS E, Athanasiadis DI, Chrysikos D, Spartalis M, et al
    Histone Deacetylase Inhibitors and Anaplastic Thyroid Carcinoma.
    Anticancer Res. 2019;39:1119-1127.
    PubMed     Text format     Abstract available


    February 2019
  10. LI MU, Gu S, Mao R, Ning Y, et al
    County Median Family Income Is an Independent Prognostic Factor for Stage IV Anaplastic Thyroid Cancer.
    Anticancer Res. 2019;39:949-956.
    PubMed     Text format     Abstract available


    January 2019
  11. ZEMBSKA A, Jawiarczyk-Przybylowska A, Wojtczak B, Bolanowski M, et al
    MicroRNA Expression in the Progression and Aggressiveness of Papillary Thyroid Carcinoma.
    Anticancer Res. 2019;39:33-40.
    PubMed     Text format     Abstract available


    December 2018
  12. DOMOSLAWSKI P, Pula B, Olbromski M, Wojtczak B, et al
    Expression of Metallothionein I/II and Ki-67 Antigen in Graves' Disease.
    Anticancer Res. 2018;38:6847-6853.
    PubMed     Text format     Abstract available


  13. FUSHIMI A, Takeyama H, Manome Y
    Effect of Heparin-Protamine Treatment on Thyroid Cancer Cell Lines.
    Anticancer Res. 2018;38:6759-6762.
    PubMed     Text format     Abstract available


  14. MASSIMINO M, Tirro E, Stella S, Frasca F, et al
    Effect of Combined Epigenetic Treatments and Ectopic NIS Expression on Undifferentiated Thyroid Cancer Cells.
    Anticancer Res. 2018;38:6653-6662.
    PubMed     Text format     Abstract available


    November 2018
  15. KIM SH, Kang JG, Kim CS, Ihm SH, et al
    Evodiamine Suppresses Survival, Proliferation, Migration and Epithelial-Mesenchymal Transition of Thyroid Carcinoma Cells.
    Anticancer Res. 2018;38:6339-6352.
    PubMed     Text format     Abstract available


  16. TURBAT-HERRERA EA, Kilpatrick MJ, Chen J, Meram AT, et al
    Cystathione beta-Synthase Is Increased in Thyroid Malignancies.
    Anticancer Res. 2018;38:6085-6090.
    PubMed     Text format     Abstract available


    September 2018
  17. OWEN C, Constantinidou A, Miah AB, Thway K, et al
    Synovial Sarcoma of the Thyroid Gland, Diagnostic Pitfalls and Clinical Management.
    Anticancer Res. 2018;38:5275-5282.
    PubMed     Text format     Abstract available


    June 2018
  18. KIM YJ, Hwang HJ, Kang JG, Kim CS, et al
    Enigma Plays Roles in Survival of Thyroid Carcinoma Cells through PI3K/AKT Signaling and Survivin.
    Anticancer Res. 2018;38:3515-3525.
    PubMed     Text format     Abstract available


  19. GADDUCCI A, Pistolesi S, Guerrieri ME, Cosio S, et al
    Malignant Transformation in Mature Cystic Teratomas of the Ovary: Case Reports and Review of the Literature.
    Anticancer Res. 2018;38:3669-3675.
    PubMed     Text format     Abstract available


    May 2018
  20. SHIH YL, Huang YH, Lin KH, Chu YD, et al
    Identification of Functional Thyroid Stimulating Hormone Receptor and TSHR Gene Mutations in Hepatocellular Carcinoma.
    Anticancer Res. 2018;38:2793-2802.
    PubMed     Text format     Abstract available


    April 2018
  21. DZIGGEL L, Gebauer N, Bartscht T, Schild SE, et al
    Performance Status and Number of Metastatic Extra-cerebral Sites Predict Survival After Radiotherapy of Brain Metastases from Thyroid Cancer.
    Anticancer Res. 2018;38:2391-2394.
    PubMed     Text format     Abstract available


    March 2018
  22. NERVO A, Gallo M, Sama MT, Felicetti F, et al
    Lenvatinib in Advanced Radioiodine-refractory Thyroid Cancer: A Snapshot of Real-life Clinical Practice.
    Anticancer Res. 2018;38:1643-1649.
    PubMed     Text format     Abstract available


    January 2018
  23. ISHIBASHI N, Maebayashi T, Aizawa T, Sakaguchi M, et al
    Computed Tomography Density Change in the Thyroid Gland Before and After Radiation Therapy.
    Anticancer Res. 2018;38:417-421.
    PubMed     Text format     Abstract available


    October 2017

  24. Thyroid Cancer and Nuclear Accidents. 1st Edition.
    Anticancer Res. 2017;37:5908.
    PubMed     Text format    


  25. DO SI, Kim HS, Kim K, Lee H, et al
    Predictive Value of Sphingosine Kinase 1 Expression in Papillary Thyroid Carcinoma.
    Anticancer Res. 2017;37:5399-5405.
    PubMed     Text format     Abstract available


    September 2017
  26. WOJTCZAK B, Pula B, Gomulkiewicz A, Olbromski M, et al
    Metallothionein Isoform Expression in Benign and Malignant Thyroid Lesions.
    Anticancer Res. 2017;37:5179-5185.
    PubMed     Text format     Abstract available


  27. AMPIL F, Ellika S, Nanda A, Vora M, et al
    Long-term Survival After Stereotactic Radiosurgery of Brain Metastases: A Case Series with 10-year Follow-up.
    Anticancer Res. 2017;37:5113-5115.
    PubMed     Text format     Abstract available


    April 2017
  28. JO S, Ha TK, Han SH, Kim ME, et al
    Myricetin Induces Apoptosis of Human Anaplastic Thyroid Cancer Cells via Mitochondria Dysfunction.
    Anticancer Res. 2017;37:1705-1710.
    PubMed     Text format     Abstract available


    March 2017
  29. RUSSO M, Malandrino P, Moleti M, D'Angelo A, et al
    Thyroid Cancer in the Pediatric Age in Sicily: Influence of the Volcanic Environment.
    Anticancer Res. 2017;37:1515-1522.
    PubMed     Text format     Abstract available


    January 2017

  30. Thyroid Cancer. A Comprehensive Guide to Clinical Management. Third Edition.
    Anticancer Res. 2017;37:361.
    PubMed     Text format    


    October 2016
  31. DAMASKOS C, Valsami S, Spartalis E, Antoniou EA, et al
    Histone Deacetylase Inhibitors: A Novel Therapeutic Weapon Against Medullary Thyroid Cancer?
    Anticancer Res. 2016;36:5019-5024.
    PubMed     Text format     Abstract available


    September 2016
  32. KASMANN L, Bolm L, Janssen S, Rades D, et al
    Prognostic Factors for Survival in Patients Treated with Multimodal Therapy for Anaplastic Thyroid Cancer.
    Anticancer Res. 2016;36:4697-700.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Diseases of the Thyroid is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: